Ratings by Barclays (Gena Wang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/17/2026 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2026 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2026 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/22/2025 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 11/24/2025 | Ultragenyx Pharma | RARE | Maintain | Overweight (N/A) |
|
Details | ||
| 11/13/2025 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2025 | 4D Molecular Therapeutics | FDMT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2025 | Moderna | MRNA | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/7/2025 | Intellia Therapeutics | NTLA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2025 | Sangamo BioSciences | SGMO | Downgrade | Equalweight (Overweight) |
0.55 (0.38) |
-30.91% | Details | |
| 11/6/2025 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/5/2025 | Sarepta Therapeutics | SRPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/4/2025 | Vertex | VRTX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/4/2025 | Solid Biosciences | SLDB | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2025 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/31/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2025 | Ionis Pharmaceuticals | IONS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2025 | Ionis Pharmaceuticals | IONS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2025 | Intellia Therapeutics | NTLA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2025 | Cellectis | CLLS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/6/2025 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 9/25/2025 | Kodiak Sciences Inc. | KOD | Upgrade | Equalweight (Underweight) |
13.72 (24.86) |
81.2% | Details | |
| 9/23/2025 | Ionis Pharmaceuticals | IONS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/3/2025 | Ionis Pharmaceuticals | IONS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/3/2025 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2025 | Ionis Pharmaceuticals | IONS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2025 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2025 | Avidity Biosciences | RNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2025 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/5/2025 | Vertex | VRTX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/5/2025 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2025 | Moderna | MRNA | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/29/2025 | Sarepta Therapeutics | SRPT | Upgrade | Equalweight (Underweight) |
13.86 (16.71) |
20.56% | Details | |
| 7/29/2025 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/28/2025 | Sarepta Therapeutics | SRPT | Downgrade | Underweight (Equalweight) |
12.88 (13.86) |
7.61% | Details | |
| 7/22/2025 | Sarepta Therapeutics | SRPT | Downgrade | Equalweight (Overweight) |
14.08 (12.88) |
-8.52% | Details | |
| 7/17/2025 | Sarepta Therapeutics | SRPT | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/16/2025 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2025 | Ionis Pharmaceuticals | IONS | Upgrade | Overweight (Equalweight) |
39.80 (74.04) |
86.03% | Details | |
| 6/26/2025 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/18/2025 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2025 | Avidity Biosciences | RNA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/16/2025 | Solid Biosciences | SLDB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2025 | Cellectis | CLLS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2025 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2025 | Vertex | VRTX | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2025 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2025 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2025 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2025 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/2/2025 | Moderna | MRNA | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/24/2025 | Cytokinetics | CYTK | New Coverage | Overweight (N/A) |
37.81 (63.19) |
67.13% | Details | |
| 4/4/2025 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2025 | bluebird bio | BLUE | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2025 | Moderna | MRNA | Downgrade | Equalweight (Overweight) |
32.99 (52.52) |
59.2% | Details | |
| 2/12/2025 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/31/2025 | Vertex | VRTX | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/20/2024 | Vertex | VRTX | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/13/2024 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/3/2024 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/15/2024 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 11/15/2024 | bluebird bio | BLUE | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2024 | Sangamo BioSciences | SGMO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2024 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/11/2024 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/6/2024 | Cellectis | CLLS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/5/2024 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/4/2024 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2024 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2024 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/4/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2024 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 9/3/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/28/2024 | Avidity Biosciences | RNA | New Coverage | Overweight (N/A) |
43.72 (14.82) |
-66.1% | Details | |
| 8/15/2024 | bluebird bio | BLUE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2024 | Solid Biosciences | SLDB | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/9/2024 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/8/2024 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2024 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/7/2024 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/6/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2024 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/5/2024 | Ultragenyx Pharma | RARE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2024 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2024 | Vertex | VRTX | Downgrade | Equalweight (Overweight) |
505.78 (456.69) |
-9.71% | Details | |
| 8/2/2024 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/2/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/25/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 6/21/2024 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/21/2024 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/16/2024 | Solid Biosciences | SLDB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2024 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/9/2024 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/8/2024 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/15/2024 | 4D Molecular Therapeutics | FDMT | New Coverage | Overweight (N/A) |
27.70 (8.48) |
-69.39% | Details | |
| 4/1/2024 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 3/18/2024 | Solid Biosciences | SLDB | Maintain | Overweight (N/A) |
|
Details | ||
| 2/29/2024 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/29/2024 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/28/2024 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/22/2024 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/6/2024 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2024 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/11/2023 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/11/2023 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/9/2023 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/6/2023 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/3/2023 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/27/2023 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/18/2023 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/9/2023 | Sangamo BioSciences | SGMO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2023 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2023 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/2/2023 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2023 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 7/21/2023 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 7/21/2023 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/23/2023 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/1/2023 | CRISPR Therapeutics | CRSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/1/2023 | bluebird bio | BLUE | Upgrade | Overweight (Equalweight) |
3.31 (4.97) |
50.15% | Details | |
| 5/24/2023 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/19/2023 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2023 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/11/2023 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/4/2023 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2023 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/8/2023 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/25/2023 | Legend Biotech Corp. | LEGN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/16/2022 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/11/2022 | Sigilon Therapeutics | SGTX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2022 | Arcturus Therapeutics | ARCT | Upgrade | Equalweight (Underweight) |
18.28 (7.11) |
-61.11% | Details | |
| 11/2/2022 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/28/2022 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2022 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/28/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2022 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2022 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/10/2022 | Beam Therapeutics Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/10/2022 | Arcturus Therapeutics | ARCT | Maintain | Underweight (N/A) |
|
Details | ||
| 8/9/2022 | CRISPR Therapeutics | CRSP | Downgrade | Equalweight (Overweight) |
81.40 (56.50) |
-30.59% | Details | |
| 8/5/2022 | bluebird bio | BLUE | Upgrade | Equalweight (Underweight) |
4.58 (4.97) |
8.52% | Details | |
| 8/5/2022 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2022 | BioCryst Pharma | BCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2022 | Editas Medicine | EDIT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2022 | Orchard Therapeutics | ORTX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2022 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 5/11/2022 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2022 | bluebird bio | BLUE | Maintain | Underweight (N/A) |
|
Details | ||
| 5/10/2022 | Arcturus Therapeutics | ARCT | Maintain | Underweight (N/A) |
|
Details | ||
| 5/5/2022 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/4/2022 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/18/2022 | BioCryst Pharma | BCRX | Downgrade | Equalweight (Overweight) |
11.39 (8.48) |
-25.55% | Details | |
| 3/21/2022 | Decibel Therapeutics Inc | DBTX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/15/2022 | Legand Biotech Corp. | LEGN | New Coverage | Overweight (N/A) |
31.02 (18.97) |
-38.85% | Details | |
| 3/7/2022 | bluebird bio | BLUE | Downgrade | Underweight (Equalweight) |
5.21 (4.97) |
-4.61% | Details | |
| 2/28/2022 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 2/7/2022 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 1/5/2022 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 12/1/2021 | Sigilon Therapeutics | SGTX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/17/2021 | LogicBio Therapeutics | LOGC | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2021 | Arcturus Therapeutics | ARCT | Maintain | Underweight (N/A) |
|
Details | ||
| 11/5/2021 | Puma Biotechnology | PBYI | Maintain | Underweight (N/A) |
|
Details | ||
| 11/5/2021 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2021 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/4/2021 | BioCryst Pharma | BCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/29/2021 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/14/2021 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2021 | Sigilon Therapeutics | SGTX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2021 | Beam Inc | BEAM | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/10/2021 | Kodiak Sciences Inc. | KOD | Maintain | Underweight (N/A) |
|
Details | ||
| 8/10/2021 | Arcturus Therapeutics | ARCT | Maintain | Underweight (N/A) |
|
Details | ||
| 8/6/2021 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | BioCryst Pharma | BCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2021 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 6/21/2021 | Arcturus Therapeutics | ARCT | Downgrade | Underweight (Equalweight) |
33.89 (7.11) |
-79.02% | Details | |
| 6/11/2021 | Vertex | VRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/17/2021 | Solid Biosciences | SLDB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2021 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2021 | BioCryst Pharma | BCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2021 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/19/2021 | Idera Pharmaceuticals | IDRA | Downgrade | Equalweight (Overweight) |
5.13 (0.43) |
-91.62% | Details | |
| 3/9/2021 | Decibel Therapeutics Inc | DBTX | New Coverage | Overweight (N/A) |
14.68 (4.91) |
-66.55% | Details | |
| 3/9/2021 | Solid Biosciences | SLDB | New Coverage | Overweight (N/A) |
9.40 (6.75) |
-28.19% | Details | |
| 3/9/2021 | Avrobio Inc. | AVRO | New Coverage | Overweight (N/A) |
11.32 (1.40) |
-87.63% | Details | |
| 3/1/2021 | Ionis Pharmaceuticals | IONS | Upgrade | Equalweight (Underweight) |
53.41 (39.80) |
-25.48% | Details | |
| 3/1/2021 | Editas Medicine | EDIT | Downgrade | Equalweight (Overweight) |
44.76 (2.00) |
-95.53% | Details | |
| 3/1/2021 | Beam Inc | BEAM | Downgrade | Equalweight (Overweight) |
88.52 (26.54) |
-70.02% | Details | |
| 3/1/2021 | Kodiak Sciences Inc. | KOD | Downgrade | Underweight (Equalweight) |
121.08 (13.72) |
-88.67% | Details | |
| 2/26/2021 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2021 | BioCryst Pharma | BCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2021 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2021 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/29/2020 | Arcturus Therapeutics | ARCT | Downgrade | Equalweight (Overweight) |
98.13 (7.11) |
-92.75% | Details | |
| 12/29/2020 | Sigilon Therapeutics | SGTX | New Coverage | Overweight (N/A) |
41.20 (22.47) |
-45.46% | Details | |
| 12/18/2020 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/24/2020 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2020 | Precision BioSciences Inc. | DTIL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2020 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2020 | Kodiak Sciences Inc. | KOD | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/7/2020 | Orchard Therapeutics | ORTX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2020 | Moderna | MRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/8/2020 | Moderna | MRNA | New Coverage | Overweight (N/A) |
58.19 (32.99) |
-43.31% | Details | |
| 5/13/2020 | Vir Biotechnology | VIR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2020 | BioCryst Pharma | BCRX | Upgrade | Overweight (Equalweight) |
3.93 (11.39) |
189.82% | Details | |
| 3/2/2020 | Beam Inc | BEAM | New Coverage | Overweight (N/A) |
22.93 (26.54) |
15.74% | Details | |
| 2/18/2020 | Eidos Therapeutics | EIDX | Downgrade | Underweight (Equalweight) |
53.86 (122.21) |
126.9% | Details | |
| 2/18/2020 | Kodiak Sciences Inc. | KOD | Downgrade | Equalweight (Overweight) |
62.77 (24.86) |
-60.4% | Details | |
| 11/27/2019 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Overweight (Equalweight) |
78.51 (61.12) |
-22.15% | Details | |
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2019 | Puma Biotechnology | PBYI | Maintain | Underweight (N/A) |
|
Details | ||
| 11/5/2019 | Halozyme Therapeutics | HALO | Upgrade | Equalweight (Underweight) |
15.55 (67.37) |
333.25% | Details | |
| 11/5/2019 | Vir Biotechnology | VIR | New Coverage | Overweight (N/A) |
15.00 (9.55) |
-36.33% | Details | |
| 11/1/2019 | Eidos Therapeutics | EIDX | Downgrade | Equalweight (Overweight) |
47.40 (122.21) |
157.83% | Details | |
| 10/24/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/5/2019 | Orchard Therapeutics | ORTX | New Coverage | Overweight (N/A) |
14.70 (16.70) |
13.61% | Details | |
| 8/9/2019 | Puma Biotechnology | PBYI | Maintain | Underweight (N/A) |
|
Details | ||
| 8/2/2019 | Clovis Oncology | CLVS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Overweight (N/A) |
12.18 (4.61) |
-62.15% | Details | |
| 3/25/2019 | Nightstar Therapeutics | NITE | Downgrade | Equalweight (Overweight) |
25.31 (35.12) |
38.76% | Details | |
| 3/25/2019 | Spark Therapeutics | ONCE | Downgrade | Equalweight (Overweight) |
113.27 (110.05) |
-2.84% | Details | |
| 2/28/2019 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/19/2019 | Spark Therapeutics | ONCE | Maintain | Overweight (N/A) |
|
Details | ||
| 12/18/2018 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/17/2018 | Nightstar Therapeutics | NITE | New Coverage | Overweight (N/A) |
11.59 (25.31) |
118.38% | Details | |
| 12/10/2018 | Tesaro | TSRO | Downgrade | Equalweight (Overweight) |
73.78 (74.96) |
1.6% | Details | |
| 11/13/2018 | LogicBio Therapeutics | LOGC | New Coverage | Overweight (N/A) |
15.11 (7.06) |
-53.28% | Details | |
| 11/8/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2018 | PTC Therapeutics | PTCT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/2/2018 | Puma Biotechnology | PBYI | Downgrade | Underweight (Equalweight) |
37.05 (6.05) |
-83.67% | Details | |
| 10/31/2018 | Clovis Oncology | CLVS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/29/2018 | Kodiak Sciences Inc. | KOD | New Coverage | Overweight (N/A) |
9.56 (24.86) |
160.04% | Details | |
| 9/24/2018 | Idera Pharmaceuticals | IDRA | New Coverage | Overweight (N/A) |
8.32 (0.43) |
-94.83% | Details | |
| 9/21/2018 | Sarepta Therapeutics | SRPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2018 | Regenxbio Inc. | RGNX | Maintain | Overweight (N/A) |
|
Details |
